Introduction Shanghai Hepu Pharmaceuticals Co., Ltd., based in Zhangjiang Hi-Tech Park's national biopharmaceutical hub, excels in drug innovation. With a strong R&D foundation, the company covers all aspects of drug development from design to mass production. Hepulatide for hepatitis B, diabetes treatments, NASH, and hyperlipidemia solutions are current focal points. Founded on April 19, 2010, Shanghai Hepu has become an influential entity in biopharmaceuticals. |